BMC

Burjeel Cancer Institute is a specialist cancer care provider based in Abu Dhabi, United Arab Emirates, and part of Burjeel Medical City and Burjeel Holdings. It brings together experienced oncology professionals and advanced medical technology to deliver multidisciplinary, personalized care, supporting patients from prevention and diagnosis through treatment and rehabilitation. The institute serves patients across Burjeel’s wider healthcare network and also welcomes international patients, offering assistance with travel, accommodation arrangements, and access to its care team.

Its services span medical and radiation oncology, cancer surgery, radiology and diagnostic imaging, breast care, and specialties covering gastrointestinal, head and neck, and bone cancers. The institute also provides psychological and psychiatric support, rehabilitation-oriented and natural therapies, and transplant services relevant to complex cancer care. Treatment and diagnostic capabilities include robotic and minimally invasive surgery, PET-CT and SPECT-CT imaging, 3D mammography, intraoperative MRI, and advanced radiation therapy. Burjeel Cancer Institute emphasizes compassionate care, tailored treatment plans, and collaboration across specialties. Its listed accreditations and recognitions include JCI, ESMO, CAP, and CARF.